Results 141 to 150 of about 214,489 (309)

New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender   +2 more
wiley   +1 more source

A Rapidly Progressive Necrotic Ulcer in an Immunocompromised Patient

open access: yes
JEADV Clinical Practice, EarlyView.
R. Almutairi   +5 more
wiley   +1 more source

Cutaneous and mucosal manifestations associated with celiac disease [PDF]

open access: yes, 2018
Beteta Gorriti, Valia Patricia   +6 more
core   +2 more sources

Genital Herpes Zoster in an Immunocompetent Adult: A Rare Presentation

open access: yes
JEADV Clinical Practice, EarlyView.
Sunil Jaiswal   +4 more
wiley   +1 more source

JAK Inhibitors in Psoriatic–Atopic Dermatitis Overlap: A Four‑Case Series

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Overlap between psoriasis and atopic dermatitis (AD) poses diagnostic and therapeutic challenges; monoclonal antibodies targeting a single axis may improve one component while worsening the other [1]. Janus kinase (JAK) inhibitors act pleiotropically and may provide simultaneous control of psoriatic and eczematous inflammation [2].
Eleonora Bongiovanni   +6 more
wiley   +1 more source

Hyperkeratotic Tinea Pedis

open access: yes
JEADV Clinical Practice, EarlyView.
Sunil Jaiswal   +4 more
wiley   +1 more source

Juvenile Mycosis Fungoides: A Multicenter Retrospective Italian Study

open access: yesJEADV Clinical Practice, EarlyView.
This multicenter retrospective study included 29 juvenile mycosis fungoides (JMF) patients from five Italian centres with confirmed histopathological diagnosis. most often presents with hypopigmented/classic variants and CD8+ phenotype. Early‐onset cases ( < 14 years) show better long‐term outcomes.
Andrea Michelerio   +8 more
wiley   +1 more source

Erythema Multiforme

open access: yesInternational Journal of Clinical Practice, 1955
openaire   +2 more sources

Home - About - Disclaimer - Privacy